Paul A. Volberding, MD

Paul A. Volberding, MD

Professor of Medicine, UCSF
Director, AIDS Research Institute
Director, Global Health Sciences Research
Co-Director, UCSF-GIVI Center for AIDS Research

Phone: (415) 476-5470 (voice)
Box 0886, UCSF
San Francisco, CA 94143-0886

View on UCSF Profiles

Cancer Center Membership

Program Member » Cancer Control

Research Summary

I was trained in Medical Oncology but became involved in the early AIDS epidemic in San Francisco based at San Francisco General Hospital. I have worked in clinical trials in HIV-related malignancies but primarily in the development of antiretroviral therapy. I am the PI and co-director with Warner Greene of the NIAID-funded UCSF-Gladstone Center for AIDS Research which supports the large community of HIV investigators in San Francisco. CFAR provides core services, pilot grants to early career stage investigators and supports a comprehensive mentorship program. In the Clinical and Translational Sciences Institute I serve as a member of the Board of Directors and formerly directed the Global Health Program. I stepped down as the Chief of the Medical Service at the San Francisco VA Medical Center in 2012 to become the Director of the UCSF AIDS Research Institute and Director of Research for UCSF Global Health Sciences. The ARI is the comprehensive University organization that links all HIV/AIDS research programs and is the central focus for communications, media relations and philanthropic support for this internationally recognized response to the HIV epidemic. Recently, the ARI became the administrative home for a unique initiative to cure HIV infection funded by amfAR, the Foundation for AIDS Research. I serve as the PI of this, working with leading scientists at UCSF, the Gladstone Institute for Virology and Immunology, and Blood Systems Research Institute. My role at GHS as the Director of Research is to convene and sustain the rapidly expanding group of UCSF faculty members conducting research in over 60 countries worldwide, and have helped create a global health Affiliate Faculty Program with over 250 members across the entire University. I also serve as the Associate Chair of the UCSF Department of Medicine for Global Health. My clinical appointment is at the VA where I maintain an active HIV outpatient practice and where I serve on the Board of Directors of the research non-profit, NCIRE. I am the director of the large internet site development and management group, the Center for HIV Information which manages seven sites including the heavily used HIV InSite. I am the Clinical Editor in Chief of the Journal of the Acquired Immunodeficiency Syndromes and serve as the Chair of the Scientific Advisory Board of the Accordia Global AIDS Foundation and the Infectious Diseases Institute at Makerere University in Kampala Uganda. I am a board member of the Pangaea Global AIDS Foundation. I am an active member of the National Academy of Medicine (formerly the Institute of Medicine) of the National Academy of Sciences and am the founder and Board Chair of the International Antiviral Society-USA. On Twitter I am @pvolberding

“View Dr. Volberding’s Elsevier Author's Bio Page"


University of Chicago, BA, 1967-1971, Biology
University of Minnesota, MD, 1971-1975, Medicine
University of Utah Medical Center, Residency, 1975-1978, Internal Medicine
University of California San Francisco, Fellow, 1978-1981, Hematology/Oncology

Professional Experience

  • 1968-1971
    Virology Laboratory Assistant, Dr. Marc Beem, University of Chicago
  • 1971-1975
    University of Minnesota School of Medicine
    Avian type C virus receptor research, Dr. Charles Moldow
  • 1975-1978
    Medicine Internship and Residency, University of Utah Medical Center, Salt Lake City
  • 1978-1979
    Clinical Fellow in Hematology/Oncology, University of California, San Francisco
    Clinical research conducted with Dr. Michael Friedman on therapy of hepatic tumors
  • 1979-1981
    Research Fellow in Hematology/Oncology, University of California, San Francisco
    Research conducted in the laboratory of Dr. Jay A. Levy studying mechanisms controlling infection with xenotropic type C retroviruses
  • 1981-1986
    Assistant Professor of Medicine, University of California, San Francisco
  • 1981-present
    Chief, Medical Oncology Division, San Francisco General Hospital
  • 1984-present
    Director, AIDS Program, San Francisco General Hospital
  • 1986-1990
    Associate Professor of Medicine, University of California, San Francisco
  • 1988-present
    Director, Center for AIDS Research, University of California, San Francisco
  • 1990-present
    Professor of Medicine, University of California, San Francisco
  • 1994-present
    Full Member, Cancer Center, University of California, San Francisco
  • 1997
    Program Leader, HIV Malignancies Research Program, UCSF Comprehensive Cancer Center
  • 2001-present
    Vice Chair, Department of Medicine, University of California, San Francisco
  • 2001-present
    Chief of the Medical Service, San Francisco Veterans Affairs Medical Center

Honors & Awards

  • 1986-1987
    National Academy of Sciences (Institute of Medicine) AIDS Policy Review Steering Committee
  • 1986-1987
    American Medical Association AIDS Panel
  • 1986-1988
    NIH AIDS Drug Selection Committee Member
  • 1986-1988
    National Institutes of Allergy and Infectious Disease AIDS Clinical Trials Group Executive Committee
  • 1987-1990
    National Academy of Sciences (Institute of Medicine) AIDS Activities Oversight Committee
  • 1990-1992
    International AIDS Society, President
  • 1992-1993
    Co-chair Institute of Medicine Round Table on AIDS Drug and Vaccine Development
  • 1993-present
    Founder and Board Chair, International AIDS Society - USA, Inc.
  • 1994-present
    National Policy Advisory Board for the HIV Cost and Services Utilization Study, RAND
  • 1997-present
    HIV Research Agenda Committee, AIDS Clinical Trials Group
  • 1998-present
    Interim Review Committee, ACTG 372
  • 1998-present
    Interim Review Committee, ACTG 368
  • 1998-present
    Center for AIDS Research Directors' Group, Chair
  • 1999-present
    Institute of Medicine

Selected Publications

  1. Shearer DW, Volberding PA, Schemitsch EH, Cook GE, Slobogean GP, Morshed S. Building Networks for Global Clinical Research: The Basics. J Orthop Trauma. 2015 Dec; 29 Suppl 12:S15-8.
    View on PubMed
  2. Chu CE, Wu F, He X, Ma Q, Cheng Y, Cai W, Volberding P, Tucker JD. Exploring the Social Meaning of Curing HIV: A Qualitative Study of People Who Inject Drugs in Guangzhou, China. AIDS Res Hum Retroviruses. 2015 Jan; 31(1):78-84.
    View on PubMed
  3. Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, Udoh IC, Cattamanchi A, Geng EH, Volberding P. Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs. Curr HIV Res. 2015; 13(3):244-6.
    View on PubMed
  4. Volberding PA. Highlights of the 2014 International AIDS Conference: update from down under. Top Antivir Med. 2014 Dec-2015 Jan; 22(5):694-7.
    View on PubMed
  5. Tucker JD, Volberding PA, Margolis DM, Rennie S, Barré-Sinoussi F. Words matter: Discussing research towards an HIV cure in research and clinical contexts. J Acquir Immune Defic Syndr. 2014 Nov 1; 67(3):e110-1.
    View on PubMed
  6. Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. JAMA. 2014 Jul 23-30; 312(4):410-25.
    View on PubMed
  7. Volberding P. HIV cure: the target is clearer but not yet close. Ann Intern Med. 2014 Apr 1; 160(7):505-6.
    View on PubMed
  8. Volberding PA. Solving the mystery of JAIDS. J Acquir Immune Defic Syndr. 2013 Aug 1; 63(4):417.
    View on PubMed
  9. Das M, Volberding P. Bringing the end in sight: consensus regarding HIV screening strategies. Ann Intern Med. 2013 Jul 2; 159(1):63-4.
    View on PubMed
  10. El-Sadr WM, Morrison JS, Quinn T, Volberding P. A chronicle of hope and promise: the world as it was, as it is, and as it can be. J Acquir Immune Defic Syndr. 2012 Aug 15; 60 Suppl 3:S49-50.
    View on PubMed
  11. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012 Jul 25; 308(4):387-402.
    View on PubMed
  12. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012 Jul 1; 60 Suppl 1:S1-18.
    View on PubMed
  13. Brown B, Henry K, Volberding P. A clinical view: a trio of HIV specialists offer their take on HIV--then, now, and in the future. Interview by Heidi M Nass. Posit Aware. 2012; 24(4):2-5.
    View on PubMed
  14. Volberding P. The impact of HIV research on health outcome and healthcare policy. Ann Oncol. 2011 Nov; 22 Suppl 7:vii50-vii53.
    View on PubMed
  15. Connick E, Bosch RJ, Aga E, Schlichtemeier R, Demeter LM, Volberding P. Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection. J Acquir Immune Defic Syndr. 2011 Sep 1; 58(1):1-8.
    View on PubMed
  16. Tabas JA, Boscardin C, Jacobsen DM, Steinman MA, Volberding PA, Baron RB. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey. Arch Intern Med. 2011 May 9; 171(9):840-6.
    View on PubMed
  17. Martin J, Volberding P. HIV and premature aging: A field still in its infancy. Ann Intern Med. 2010 Oct 5; 153(7):477-9.
    View on PubMed
  18. Dykes C, Mukherjee AL, Bosch RJ, Connick E, Volberding PA, Demeter LM. Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):132-4.
    View on PubMed
  19. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010 Jul 21; 304(3):321-33.
    View on PubMed
  20. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010 Jul 3; 376(9734):49-62.
    View on PubMed

Go to UCSF Profiles, powered by CTSI